Protalix Biotherapeutics Inc. buy marge
Start price
12.04.17
/
50%
€10.35
Target price
26.07.17
€20.00
Performance (%)
-40.29%
End price
26.07.17
€6.18
Summary
This prediction ended on 26.07.17 with a price of €6.18. The BUY prediction by marge for Protalix Biotherapeutics Inc. performed very badly with a performance of -40.29%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 28.324% | 28.324% | -4.639% | 50.152% |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% | 57.331% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% | 88.129% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% | 49.690% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% | 59.994% |
Comments by marge for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease
(Vom Mitglied beendet)